Publication | Closed Access

A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation

Oncogenic AgentMedicineApoptosisCell DeathCancer BiologyArsenic TrioxideAnti-cancer AgentPharmacologyCell BiologyLung CancerCancer ResearchOxidative Stress